RE:Gentleman's bet on q4 resultsBeen wondering to what extent EU GMP certification will help CC Pharma margins if at all this quarter? Revenues were 88 million last quarter and they've also been approved for a small amount of growing capacity in Germany so it could be impactful. Revenues should remain consistent or marginally higher in the German market seeing as pharmacies were considered esseential and patients would use more product if anything. As for Canada, 180 million was recorded in a month where stores had no way to sell for a period of time so i could easily see that number ticking up to 190-200 million when june numbers are released. Aph. will benefit disproportionately from its peers if Ontario sales growth is impressive. Ill shoot for 155 million in revenues. Cost per gram should decrease with aphria one and diamond at full capacity. Really not sure if its a profitable quarter or not.